|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CARDIOVASCULAR |
1 Department of Physiology, Stritch School of Medicine, Loyola University Chicago, 2160 South First Avenue, Maywood, IL 60153, USA
Embryonic stem cell-derived cardiomyocytes (ESdCs) have been proposed as a source for cardiac cell-replacement therapy. The aim of this study was to determine the Ca2+-handling mechanisms that determine the frequency and duration of spontaneous Ca2+ transients in single ESdCs. With laser scanning confocal microscopy using the Ca2+-sensitive dye Fluo-4/AM, we determined that spontaneous Ca2+ transients in ESdCs at the onset of beating (day 9) depend on Ca2+ entry across the plasma membrane (50%) whereas Ca2+-induced Ca2+ release is the major contributor to Ca2+ transients in ESdCs after 16 days (72%). Likewise, Ca2+ extrusion in 9-day-old ESdCs depends on Na+Ca2+ exchange (50.0 ± 8%) whereas Ca2+ reuptake by the sarco(endo)plasmic Ca2+ ATPase (72 ± 5%) dominates in further differentiated cells. Spontaneous Ca2+ transients were suppressed by the inositol-1,4,5-trisphosphate (IP3) receptor (IP3R) blocker 2-aminoethoxydiphenyl borate (2-APB) and the phospholipase C blocker U73122 but continued in the presence of caffeine. Stimulation of IP3 production by phenylephrine or endothelin-1 had a positive chronotropic effect that could be reversed by U73122 and 2-APB. The presence of Ca2+-free solution and block of L-type Ca2+ channels by nifedipine also resulted in a cessation of spontaneous activity. Overall, IP3R-mediated Ca2+ release in ESdCs is translated into a depolarization of the plasma membrane and a whole-cell Ca2+ transient is subsequently induced by voltage-dependent Ca2+ influx. Although ryanodine receptor-mediated Ca2+ release amplifies the IP3R-induced trigger for the Ca2+ transients and modulates its frequencies, it is not a prerequisite for spontaneous activity. The results of this study offer important insight into the role of IP3R-mediated Ca2+ release for pacemaker activity in differentiating cardiomyocytes.
(Received 1 December 2006;
accepted after revision 16 March 2007;
first published online 22 March 2007)
Corresponding author K. Banach: Department of Physiology, Stritch School of Medicine, Loyola University Chicago, 2160 South First Avenue, Maywood, IL 60153, USA. Email: kbanac1{at}lumc.edu
Related Article
J. Physiol. 2007 581: 883-884.
This article has been cited by other articles:
![]() |
J. Satin, I. Itzhaki, S. Rapoport, E. A. Schroder, L. Izu, G. Arbel, R. Beyar, C. W. Balke, J. Schiller, and L. Gepstein Calcium Handling in Human Embryonic Stem Cell-Derived Cardiomyocytes Stem Cells, August 1, 2008; 26(8): 1961 - 1972. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Bootman and H. L. Roderick Why, where, and when do cardiac myocytes express inositol 1,4,5-trisphosphate receptors? Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H579 - H581. [Full Text] [PDF] |
||||
![]() |
J. P. Fahrenbach, R. Mejia-Alvarez, and K. Banach The relevance of non-excitable cells for cardiac pacemaker function J. Physiol., December 1, 2007; 585(2): 565 - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, J. D. Fu, C. W. Siu, and R. A. Li Functional Sarcoplasmic Reticulum for Calcium Handling of Human Embryonic Stem Cell-Derived Cardiomyocytes: Insights for Driven Maturation Stem Cells, December 1, 2007; 25(12): 3038 - 3044. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Roderick and M. D. Bootman Pacemaking, arrhythmias, inotropy and hypertrophy: the many possible facets of IP3 signalling in cardiac myocytes J. Physiol., June 15, 2007; 581(3): 883 - 884. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |